Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Appointed director
CC transcript

Synaptogenix, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
07/16/2021 8-K Quarterly results
07/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2021 4 Alkon Daniel L. (See Remarks) has filed a Form 4 on Synaptogenix, Inc.
Txns: Granted 80,000 shares @ $0
07/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/07/2021 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/07/2021 EFFECT Form EFFECT - Notice of Effectiveness:
07/02/2021 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
06/29/2021 D Form D - Notice of Exempt Offering of Securities:
06/25/2021 SC 13G INTRACOASTAL CAPITAL, LLC reports a 10% stake in Synaptogenix, Inc.
06/24/2021 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
06/21/2021 8-K Other Events
06/17/2021 3/A SCHECHTER JONATHAN (Director) has filed a Form 3/A on Synaptogenix, Inc.
06/16/2021 8-K Quarterly results
06/16/2021 4 Alkon Daniel L. (Chief Scientific Officer) has filed a Form 4 on Synaptogenix, Inc.
Txns: Bought 10,000 shares @ $8.26, valued at $82.6k
06/16/2021 4 Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.
Txns: Bought 10,000 shares @ $8.3, valued at $83k
06/14/2021 3 Singer William S. (Director) has filed a Form 3 on Synaptogenix, Inc.
06/14/2021 3 WEINSTEIN ROBERT (CFO) has filed a Form 3 on Synaptogenix, Inc.
06/14/2021 3 Silverman Joshua (Director) has filed a Form 3 on Synaptogenix, Inc.
06/14/2021 3 SCHECHTER JONATHAN (Director) has filed a Form 3 on Synaptogenix, Inc.
06/14/2021 3 Perry George (Director) has filed a Form 3 on Synaptogenix, Inc.
06/14/2021 3 Alkon Daniel L. (Chief Scientific Officer) has filed a Form 3 on Synaptogenix, Inc.
06/14/2021 3 Bernstein Bruce (Director) has filed a Form 3 on Synaptogenix, Inc.
06/14/2021 3 TUCHMAN ALAN J (CEO) has filed a Form 3 on Synaptogenix, Inc.
06/04/2021 8-A12B Form 8-A12B - Registration of securities [Section 12(b)]:
05/14/2021 10-Q Quarterly Report for the period ended March 31, 2021
04/30/2021 8-K Financial Statements and Exhibits
Docs: "The unaudited pro forma consolidated balance sheet of the Company as of December 31, 2020"
04/30/2021 SC 13G Hewlett Fund LP reports a 9% stake in SYNAPTOGENIX, INC.
04/30/2021 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy